Pharmaceuticals, Biotechnology and Life Sciences
Nasdaq Hearing Cancellation and Continued ListingFOSTER CITY, Calif., Oct. 15, 2025 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or…
OSE Immunotherapeutics Reports First Half 2025 Financial Results NANTES, France, October 15, 2025 – 7:00pm CET – OSE Immunotherapeutics SA…
Aggregated presentation by day and by marketStatement of transactions in own shares from October 06th to October 10th 2025 Name of…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE…
Recognition for groundbreaking work and pioneering space manufacturingBOSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) — Fast Company has named Eascra Biotech,…
HOUSTON, Oct. 15, 2025 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) is collaborating with Spanios on a non-clinical study…
Findings Presented at ECNP 2025 in Amsterdam Support the Potential for a Safe At-Home Treatment Option in Treatment-Resistant DepressionMUNICH, Oct.…
WATERTOWN, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing…
FOSTER CITY, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) — Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), today announced the…
WALTHAM, Mass., Oct. 13, 2025 (GLOBE NEWSWIRE) — Spyre Therapeutics, Inc. (“Spyre” or the “Company”) (Nasdaq: SYRE), a clinical-stage biotechnology…